Geriatrics Flashcards
What % of the population is over 65 in 2030 and 2050
By 2030, 20% of US > 65 y/o
By 2050, 2 billion people worldwide over 60 y/o
What is aging (4)
Universal and progressive physiologic process
Decreasing end-organ reserve
Decreased functional capacity
Increased homeostatic imbalance
Increasing incidence of pathophysiologic processes
Memory and aging
Memory decline
40% of people > 60 y/o have some sort of memory decline
Not inevitable
Relates to ability to complete ADL’s
NS structure changes with aging
Cerebral atrophy; brain size shrinks. White matter shrinks more than gray matter. Don’t loose neurons but we lose functioning
Decrease grey matter;
Neuronal shrinkage (only a small neuron loss)
Decrease white matter;
Increases in ventricular size between the atrophy and decreases in gray/white matter leads to-> Progressive loss of memory, balance, mobility
NS and aging changes with nerve transmission
of synapses or amount of neurotransmitters decrease/ don’t work aswell because in decrease in number of synapses or a decrease in nt release or decrease amount built.
Animal studies;
Significant decrease in Dopamine, Ach, norepi and serotonin (all not)
No change in glutamate
Coupling of CMRO2, CBF, EEG unchanged
Neuraxial changes with Aging
Decreased epidural space
Increased permeability of dura
Decreased volume of CSF
Decreased diameter/number of myelinated fibers in dorsal and ventral nerve roots
Peripheral nervous system changes with aging
Inter-Schwann cell distance decreased
Conduction velocity decreased
Elderly more sensitive to Neuraxial blocks and Peripheral nerve blocks
Cardiac changes with aging (8)
Myocyte number decreases
LV wall thickens
SA node cells decrease
Conduction velocity decrease
Thickened and calcific aortic valve
Decreased contractility
Increased ventricular stiffness…higher filling pressure
Less Beta-adrenergic sensitivity
Tachy/brady syndrome
SA node cells decrease; don’t have as regular rhythm= more susceptible to a fib or brady tachy syndrome where the SA node doesntk now how to be regular so it speeds up and then slows down; put on Beta blocker to keep tachycardia at bay and they will have a pacemaker inserted for safety baselin.
Response of decrease beta adrenergic sensitivity
↓ maximal heart rate and ejection fraction during stress= decreased max rate
Vessel changes with aging
Vascular stiffness;
Due to Breakdown of collagen and elastin
Less NO related vasodilation; cant stretch and bound back
Early wave deflection…increased afterload, diastolic dysfunction
What is early wave deflection
As stroke volume is ejected = have arterial wave to periphery and to return back to the heart because of increased afterload it causes some diastolic dysfunction = stiff vessels that cant relax and we get the wave deflected back to the heart.
Pulmonary-Structural chagnes with aging
Loss of elastic recoil and loss of surfactant
Enlarged bronchioles and alveolar ducts
Early collapse of small airways during exhalation
Loss of vertebral height and calcification of vertebra
Loss of elastic recoil and loss of surfactant results in ……
Increased lung compliance
Enlarged bronchioles and alveolar ducts
Early collapse of small airways during exhalation causes……(3)
Increased anatomic dead space
Increased closing capacity
Impaired gas exchange
Loss of vertebral height and calcification of vertebra results in…..
Barrel chest
Diaphragmatic flattening
Chest wall stiffness….increased work of breathing
Changes to pulmonary function with aging
Decrease fev 1 by……
total lung capacity about the same
↓ vital capacity
↑ closing capacity
↑ residual volume
Decrease muscle mass and ↑ closing capacity
Decrease FEV1 by 6-8% per decade
Weaker pharyngeal muscles
Weaker pharyngeal muscles results in …….. (4)
Decreased clearance of secretions
Less efficient coughing
Decreased esophageal motility
Less protective upper airway reflexes
VQ matching with aging
Relationship between FRC and closing capacity;
Mismatch increases
Most important MOA for alveolar-arterial oxygen gradient
Shunt increases , arterial oxygenation declines
Renal changes with aging
GFR decreases;
Comorbidities may exacerbate. less IVP dye excretion
Blunted responses to aldosterone, vasopressin, renin;
Trouble adjusting Fluid &Electrolyte
Retention and UTI’s more common; difficult to contract because of decreased muscle